Correlation Between Erytech Pharma and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Erytech Pharma and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erytech Pharma and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erytech Pharma SA and Eliem Therapeutics, you can compare the effects of market volatilities on Erytech Pharma and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erytech Pharma with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erytech Pharma and Eliem Therapeutics.
Diversification Opportunities for Erytech Pharma and Eliem Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Erytech and Eliem is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Erytech Pharma SA and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Erytech Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erytech Pharma SA are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Erytech Pharma i.e., Erytech Pharma and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Erytech Pharma and Eliem Therapeutics
If you would invest 78.00 in Erytech Pharma SA on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Erytech Pharma SA or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.61% |
Values | Daily Returns |
Erytech Pharma SA vs. Eliem Therapeutics
Performance |
Timeline |
Erytech Pharma SA |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eliem Therapeutics |
Erytech Pharma and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Erytech Pharma and Eliem Therapeutics
The main advantage of trading using opposite Erytech Pharma and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erytech Pharma position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.Erytech Pharma vs. Genfit | Erytech Pharma vs. Eliem Therapeutics | Erytech Pharma vs. HCW Biologics | Erytech Pharma vs. Aptorum Group Ltd |
Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |